ID   5-8F/Erbitux
AC   CVCL_S665
SY   5-8F-Erbitux
DR   Cosmic; 1459416
DR   Wikidata; Q54603664
RX   PubMed=21122407;
CC   Problematic cell line: Contaminated. Parent cell line (5-8F) has been shown to be an hybrid of HeLa and a cell line of unknown origin.
CC   Selected for resistance to: DrugBank; DB00002; Cetuximab (Erbitux).
CC   Sequence variation: Gene fusion; HGNC; 1490; CAPZA2 + HGNC; 7029; MET; Name(s)=CAPZA2-MET (from parent cell line).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C528 ! 5-8F
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 14
//
RX   PubMed=21122407; DOI=10.3760/cma.j.issn.0253-3766.2010.08.004;
RA   Zuo Q., Luo R.-C.;
RT   "Relationship between the insulin-like growth factor 1 receptor
RT   signaling pathway and the resistance of nasopharyngeal carcinoma to
RT   cetuximab.";
RL   Zhonghua Zhong Liu Za Zhi 32:575-579(2010).
//